Episode 514: Blockbuster News About Lipoprotein(a) Therapy
Sep 8, 2026 - 29:53
Radio and PodcastLive Radio & PodcastsHealth
Episode 498: Do You Want a One and Done Cholesterol Infusion? The Long Road Ahead
Dr. Joel Kahn dives into a groundbreaking Phase 1 trial of Verve 102, a one-time intravenous gene-editing treatment that silences the PCSK9 gene to produce lasting LDL cholesterol reduction. Among 35 participants, the hi...
Related Episodes
Continue listening to more episodes from Heart Doc VIP with Dr. Joel Kahn.
Episode 513: The Emerging Science of Pomegranates and Urolithin A
Sep 4, 2026 - 26:52
Episode 511: Vascular Disease at Age 23 (Protect Our Young)
Aug 25, 2026 - 27:41
Episode 510: The TG/HDL Ratio and Your Risk of Disease
Aug 18, 2026 - 26:56
Episode 509: How to Upgrade Your Gene Activity in 4 Weeks
Aug 11, 2026 - 25:28
Episode 508: Why Cooking to Reduce AGE Content Is a Healthy Habit
Aug 4, 2026 - 30:22
Episode 507: The Nuance of How Much Dietary Protein for Optimal Health
Jul 28, 2026 - 22:45